CNTXVSJBIO• 3 Months (Normalized)
CNTX vs JBIO (Context Therapeutics Inc. vs Jade Biosciences Inc.)
Showing Closing Date Range from Jun, 16 to Sep, 14, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
CNTX Performance $0.38
-41.72%
Context Therapeutics Inc.
Normalized Baseline0.00%
JBIO Performance $18.55
+19.45%
Jade Biosciences Inc.
Normalized Baseline0.00%
Alpha Spread Margin JBIO LEADS
-61.17%
JBIO outperforming by 61.17%
CNTXJBIO
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
CNTX JBIO
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(62 dates)
| Date | CNTX Price | CNTX Gain (%) | JBIO Price | JBIO Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 14, 2026 | $0.38 | -41.72% | $18.55 | +19.45% | -61.17% |
| Sep 11, 2026 | $0.35 | -46.15% | $17.89 | +15.20% | -61.35% |
| Sep 10, 2026 | $0.37 | -43.69% | $19.14 | +23.25% | -66.94% |
| Sep 09, 2026 | $0.37 | -43.08% | $19.06 | +22.73% | -65.81% |
| Sep 08, 2026 | $0.38 | -42.15% | $19.45 | +25.24% | -67.39% |
| Sep 04, 2026 | $0.36 | -44.31% | $19.90 | +28.14% | -72.45% |
| Sep 03, 2026 | $0.36 | -44.15% | $19.85 | +27.82% | -71.97% |
| Sep 02, 2026 | $0.36 | -44.15% | $21.40 | +37.80% | -81.95% |
| Sep 01, 2026 | $0.36 | -44.00% | $21.02 | +35.35% | -79.35% |
| Aug 31, 2026 | $0.39 | -40.00% | $21.36 | +37.54% | -77.54% |
| Aug 28, 2026 | $0.38 | -40.92% | $20.84 | +34.19% | -75.11% |
| Aug 27, 2026 | $0.42 | -36.00% | $21.29 | +37.09% | -73.09% |
| Aug 26, 2026 | $0.42 | -34.77% | $21.33 | +37.35% | -72.12% |
| Aug 25, 2026 | $0.44 | -33.08% | $21.84 | +40.63% | -73.71% |
| Aug 24, 2026 | $0.47 | -28.46% | $21.33 | +37.35% | -65.81% |
Page 1 of 5